Herpes Simplex Infection: Complete ICD-11 Coding Guide (1F00)

1. Introduction

Herpes simplex infection represents one of the most prevalent viral infections worldwide, affecting millions of people across all age groups and geographic regions. Caused by herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), belonging to the Herpesviridae family, this condition is characterized by recurrent vesicular lesions that primarily affect skin and mucous membranes, although it may compromise other organ systems in specific situations.

The clinical importance of herpes simplex infection transcends individual morbidity, representing a significant challenge for global public health. HSV-1 is traditionally associated with orofacial lesions, while HSV-2 predominantly relates to genital infections, although this distinction is not absolute. The most striking characteristic of these viruses is their ability to establish latency in sensory nerve ganglia, remaining in the body indefinitely and potentially reactivating periodically.

The prevalence of infection varies considerably according to geographic region, socioeconomic conditions, and age group, being considered endemic in practically all human populations. Transmission occurs mainly through direct contact with active lesions or secretions containing the virus, including vertical transmission during delivery and horizontal transmission through intimate contact.

Precise coding of this condition in the ICD-11 system is critical for multiple purposes: appropriate epidemiological surveillance, proper allocation of public health resources, planning of preventive strategies, clinical research, and ensuring adequate reimbursement for services provided. The transition from ICD-10 to ICD-11 brought greater specificity and clarity in the classification of herpetic infections, allowing better tracking and management of this globally prevalent condition.

2. Correct ICD-11 Code

Code: 1F00

Description: Herpes simplex infection

Parent category: Viral infections characterized by lesions on the skin or mucous membranes

Official definition: Any condition caused by an infection with herpes simplex virus (human herpesvirus 1 and 2). Confirmation is made by identification of herpes simplex virus type 1 or 2.

This code represents the main category for all manifestations of herpes simplex virus infection, serving as an umbrella code for the various clinical presentations of this condition. Code 1F00 should be used when there is laboratory confirmation or consistent clinical diagnosis of HSV-1 or HSV-2 infection, regardless of anatomical location or severity of manifestation.

The hierarchical structure of ICD-11 positions this code within viral infections that manifest primarily through cutaneomucous lesions, reflecting the most common clinical presentation of the disease. This categorization facilitates the search and application of the correct code, grouping conditions with similar pathophysiological characteristics and clinical manifestations.

The code has four subcategories that allow greater specificity in coding according to the particular clinical manifestation, and relates to eight other codes within the classification system, demonstrating the complexity and diversity of presentations of this viral infection. Diagnostic confirmation can be performed through various laboratory methods, including viral culture, antigen detection, serology, and molecular techniques such as PCR.

3. When to Use This Code

The code 1F00 should be applied in specific clinical situations where there is evidence of active infection or documented history of infection by herpes simplex virus. Below are detailed practical scenarios:

Scenario 1: Recurrent herpes labialis Patient presents with a history of recurrent episodes of vesicles grouped on an erythematous base in the perioral region, preceded by tingling or burning sensation. Clinical diagnosis is established by the typical presentation, history of recurrences, and characteristic location. Even without laboratory confirmation, when the clinical presentation is unequivocal and there is confirmed prior history, code 1F00 is appropriate.

Scenario 2: Primary herpetic gingivostomatitis Child or young adult develops an acute presentation of multiple painful ulcers on oral mucosa, edematous and bleeding gingiva, fever, odynophagia, and cervical lymphadenopathy. This presentation frequently represents primary HSV-1 infection and requires code 1F00, especially when confirmed by laboratory tests or when the clinical presentation is characteristic.

Scenario 3: Primary or recurrent genital herpes Patient reports the appearance of painful vesicles in the genital or perianal region, which progress to shallow ulcers. There may be systemic symptoms in primary infection, such as fever, malaise, and inguinal lymphadenopathy. Confirmation may be clinical in recurrent episodes with typical pattern, or laboratory-based through PCR or culture of lesion swabs. Code 1F00 applies to both HSV-1 and HSV-2 infections in this location.

Scenario 4: Eczema herpeticum Patient with preexisting atopic dermatitis develops extensive dissemination of herpetic vesicles over areas of compromised skin, constituting a severe complication of HSV infection. This condition represents a dermatological emergency and requires code 1F00 with appropriate documentation of the extent and severity of cutaneous involvement.

Scenario 5: Herpetic whitlow Healthcare professional or individual with exposure to oral secretions develops painful herpetic infection in the fingertip pulp, with vesicles, intense edema, and erythema. Differential diagnosis with bacterial infections is essential, and laboratory confirmation is recommended. Once herpetic etiology is confirmed, code 1F00 is appropriate.

Scenario 6: Neonatal herpes Newborn develops manifestations of herpetic infection acquired during delivery or in the perinatal period, which may present with cutaneous lesions, ocular involvement, or systemic manifestations. This is a serious condition requiring urgent diagnosis and treatment, and code 1F00 should be used with detailed documentation of the form of presentation and extent of involvement.

4. When NOT to Use This Code

It is essential to distinguish situations where code 1F00 is not appropriate, avoiding coding errors that compromise epidemiological data and clinical management:

Specific exclusion: Herpangina If the patient presents with ulcers in the posterior oropharynx, especially on the tonsillar pillars and soft palate, associated with fever and dysphagia, but caused by enterovirus (Coxsackie A), code 61181798 should be used. Although the term "herpes" is present in the condition's name, herpangina is not caused by herpes simplex virus, but rather by enterovirus. The differentiation is crucial: herpangina predominantly affects the posterior oropharynx, whereas herpetic gingivostomatitis affects the gingiva and anterior oral mucosa.

Varicella-zoster infection Vesicular lesions caused by Varicella-zoster virus (herpes zoster or shingles) should not be coded as 1F00. Although both belong to the Herpesviridae family, they are distinct viruses with characteristic clinical manifestations. Herpes zoster presents unilateral dermatomal distribution, whereas herpes simplex does not follow specific neural distribution.

Other viral infections with vesicular lesions Conditions such as molluscum contagiosum (poxvirus), viral warts (papillomavirus), or various viral exanthems should not be confused with herpes simplex infection. The morphology of lesions, distribution pattern, and clinical course differ significantly.

Traumatic lesions or aphthous ulcers Recurrent aphthous ulcers (aphthous stomatitis) are frequently confused with oral herpes, but have a distinct, non-viral etiology. Aphthous ulcers are typically single or few in number, with regular borders and yellowish base, without preceding vesicles, and do not respond to antivirals.

Asymptomatic carriers Individuals with positive serology for HSV but without active clinical manifestations should not receive code 1F00 as a principal diagnosis. The mere presence of antibodies indicates prior exposure, but does not constitute codifiable active infection.

5. Coding Step by Step

Step 1: Assess diagnostic criteria

The diagnosis of herpes simplex infection is based on the combination of characteristic clinical presentation and, when available, laboratory confirmation. The criteria include:

Typical clinical manifestations: Presence of vesicles grouped on an erythematous base, which progress to pustules, crusts, and subsequently scarring. The location may be perioral, genital, digital, or in other cutaneomucous areas. Prodromal symptoms such as tingling, pruritus, or burning frequently precede the lesions.

Laboratory confirmation: Although clinical diagnosis is sufficient in many cases, especially in recurrences with a typical pattern, laboratory confirmation is recommended in primary infections, atypical cases, or when there are important therapeutic or epidemiological implications. Methods include PCR (gold standard), viral culture, antigen detection by immunofluorescence, and serology to distinguish primary from recurrent infection.

Necessary evaluations: Detailed clinical history including frequency of recurrences, triggering factors, risk exposures, and impact on quality of life. Careful physical examination documenting location, extent, and characteristics of lesions. In severe or atypical cases, complementary laboratory evaluation.

Step 2: Verify specifiers

Herpes simplex infection presents important variations that should be documented:

Primary infection versus recurrence: The first infection tends to be more symptomatic and prolonged, while recurrences are generally milder and self-limited. This distinction has prognostic and therapeutic implications.

Anatomical location: Orofacial, genital, non-genital cutaneous, ocular, or disseminated. The location influences management and prognosis.

Severity: Mild (few lesions, minimal discomfort), moderate (multiple lesions, significant symptoms), or severe (extensive, systemic involvement, complications).

Viral type: HSV-1 or HSV-2, when identified by specific tests. Although HSV-1 predominates in orofacial infections and HSV-2 in genital infections, there is increasing overlap.

Complications: Presence of eczema herpeticum, encephalitis, aseptic meningitis, hepatitis, or other serious manifestations requiring additional coding.

Step 3: Differentiate from other codes

Poxvirus infections: Caused by DNA viruses of the Poxviridae family, including molluscum contagiosum and smallpox (eradicated). Key difference: molluscum contagiosum lesions are firm umbilicated papules, not vesicles, and do not cause prodromal symptoms. The course is more indolent and there are no recurrences in the same pattern as herpes simplex.

Human papillomavirus infection of skin or mucous membrane: Caused by HPV, manifests as warts of variable morphology (common, plantar, genital). Key difference: warts are persistent hyperkeratotic lesions, not vesicular, without an acute phase of vesicles-pustules-crusts. There are no prodromal symptoms and the course is chronic without episodes of acute recurrence.

Varicella-zoster infections: Caused by Varicella-zoster virus, manifesting as varicella (primary infection) or herpes zoster (reactivation). Key difference: herpes zoster presents strict unilateral dermatomal distribution, frequently with intense neuropathic pain. Vesicles appear in groups along the dermatome, do not recur in the same pattern as herpes simplex, and rarely affect oral or genital mucosae.

Step 4: Necessary documentation

Checklist of mandatory information:

Date of symptom onset
Precise anatomical location of lesions
Morphological characteristics (vesicles, ulcers, crusts)
Associated symptoms (pain, pruritus, systemic symptoms)
History of previous episodes and frequency
Identified triggering factors
Laboratory test results when performed
Viral type (HSV-1 or HSV-2) if identified
Relevant comorbidities (immunosuppression, atopic dermatitis)
Treatment instituted and response

Adequate documentation: The documentation should be sufficiently detailed to justify the chosen code and allow continuity of care. Clinical photographs are valuable when available and consented. In electronic systems, using structured fields facilitates accurate coding and data retrieval.

6. Complete Practical Example

Clinical Case

A 28-year-old patient seeks medical care with a complaint of painful lesions in the genital region for three days. She reports that approximately five days ago she began experiencing a burning sensation and discomfort in the vulvar region, followed by the appearance of small grouped vesicles that rapidly ruptured, forming extremely painful shallow ulcers. She also presents with intense dysuria, low-grade fever (37.8°C), generalized malaise, and painful swelling in the bilateral inguinal region.

In the history, the patient mentions a new relationship two months ago and denies previous similar episodes. She has no history of previous sexually transmitted infections. She denies significant comorbidities and does not use regular medications. She denies oral lesions or lesions in other locations.

On physical examination, multiple shallow ulcers are observed, measuring 2-5mm in diameter, with erythematous borders and clean base, grouped in the vulvar and perineal region. Some intact vesicles are still visible. Bilateral inguinal lymphadenopathy that is painful on palpation. The remainder of the physical examination shows no significant alterations.

Due to the clinical presentation suggestive of primary genital herpes infection, a swab of the lesions was collected for PCR specific for HSV-1 and HSV-2. Serologies for other sexually transmitted infections were also requested as part of the comprehensive evaluation.

The PCR result returned positive for HSV-2, confirming the diagnosis of primary genital herpes infection. Serologies for other infections were negative.

Coding Step by Step

Criteria analysis:

Typical clinical presentation: Grouped vesicles evolving into painful ulcers in the genital region, with prodromal symptoms (preceding burning), systemic symptoms (fever, malaise), and regional lymphadenopathy. This presentation is characteristic of primary genital herpes infection.
Laboratory confirmation: Positive PCR for HSV-2 definitively confirms the diagnosis, eliminating diagnostic doubt and allowing identification of the specific viral type.
Exclusion of differential diagnoses: The morphology of the lesions, temporal evolution, associated symptoms, and laboratory confirmation exclude other causes of genital ulcers such as syphilis, chancroid, lymphogranuloma venereum, traumatic ulcers, or non-infectious dermatoses.
Severity and extent: This is a symptomatic primary infection with multiple lesions and systemic symptoms, characterizing a moderate to severe presentation that justifies antiviral treatment and follow-up.

Code selected: 1F00 - Herpes simplex infection

Complete justification:

The code 1F00 is the appropriate code because:

There is definitive laboratory confirmation of infection by herpes simplex virus type 2
The clinical presentation is characteristic and unequivocal
There are no applicable exclusion criteria
The code adequately captures the patient's primary condition
It allows appropriate epidemiological tracking of this sexually transmitted infection

Applicable complementary codes:

Depending on the coding system used and need for additional specificity, complementary codes may be considered for:

Specific genital location
Characterization as primary infection
Significant associated symptoms (fever, lymphadenopathy) if symptom coding is required
Contact with sexually transmitted infection (for epidemiological purposes)

Final documentation: Primary genital herpes infection caused by HSV-2, confirmed by PCR, with multiple vulvar and perineal ulcers, fever, malaise, and bilateral inguinal lymphadenopathy. Antiviral treatment initiated. Guidance on transmission, recurrences, and future management provided. Outpatient follow-up scheduled.

7. Related Codes and Differentiation

Within the Same Category

Poxvirus Infections

When to use: Applicable when the etiological agent is a virus from the Poxviridae family, such as molluscum contagiosum virus, which causes umbilicated papular skin lesions, or historically the smallpox virus (eradicated). Also includes zoonotic infections such as monkeypox.

Main difference vs. 1F00: Poxvirus lesions are typically firm papules, often with characteristic central umbilication, and do not follow the vesicle-pustule-crust pattern of herpes simplex. There are no prodromal symptoms of tingling or burning. Molluscum contagiosum lesions persist for months, not days to weeks, and do not present recurrences in the same episodic pattern as herpes. Diagnostic confirmation is based on distinct clinical characteristics and, when necessary, histopathology showing characteristic cytoplasmic inclusion bodies.

Human Papillomavirus Infection of Skin or Mucous Membrane

When to use: Appropriate for warts caused by HPV in various locations (common, plantar, flat, genital/condyloma acuminatum). Lesions are epithelial proliferations induced by different HPV types with hyperkeratosis.

Main difference vs. 1F00: Warts are solid, hyperkeratotic lesions with slow growth and prolonged persistence, completely different from acute vesicles of herpes simplex. There is no vesicular phase, prodromal symptoms, or acute recurrent episodes. Condyloma acuminatum (genital warts) may coexist with genital herpes, but are morphologically distinct: verrucous, exophytic, or papillomatous lesions versus shallow herpetic ulcers. Differential diagnosis is usually clear by morphological appearance, but may require biopsy in atypical cases.

Varicella-zoster Infections

When to use: Appropriate code for varicella (primary infection by Varicella-zoster virus, common in childhood) or herpes zoster (reactivation of latent virus in nerve ganglia, common in adults and elderly).

Main difference vs. 1F00: Herpes zoster presents strict unilateral dermatomal distribution, following the course of a specific sensory nerve, whereas herpes simplex does not respect neural distribution. Herpes zoster rarely affects oral or genital mucosae, common sites of herpes simplex. Neuropathic pain is much more prominent in zoster, often preceding skin lesions by days. Varicella presents with generalized eruption with lesions in different evolutionary stages simultaneously, different from herpes simplex which affects localized areas. Although both are herpesviruses, they are distinct viral species with different clinical behavior.

Differential Diagnoses

Recurrent aphthous stomatitis: Recurrent oral ulcers of non-viral etiology, without preceding vesicular phase, typically single ulcers or small number with regular borders and yellowish base. Do not respond to antivirals.

Impetigo: Bacterial skin infection by Staphylococcus or Streptococcus, with characteristic meliceric crusts, without typical herpetiform vesicles or specific prodromal symptoms.

Primary syphilis: Single, painless genital ulcer with hardened borders (hard chancre), completely different from multiple painful ulcers of genital herpes. Confirmation by specific serological tests.

Behçet disease: Recurrent oral and genital ulcers, but part of multisystemic syndrome with ocular, cutaneous, and vascular manifestations, without viral etiology.

8. Differences with ICD-10

In the ICD-10 system, herpes simplex virus infections were coded primarily under the codes:

A60: Anogenital herpesvirus infection
B00: Herpesviral infections

ICD-10 separated herpetic infections mainly by anatomical location, with specific codes for genital herpes (A60) versus other locations (B00), and subdivisions for specific manifestations such as herpetic encephalitis, vesicular dermatitis, gingivostomatitis, among others.

Main changes in ICD-11:

The transition to ICD-11 brought significant structural reorganization. Code 1F00 functions as a comprehensive category for all herpes simplex virus infections, regardless of location, with subcategories that allow specification when necessary. This hierarchical approach offers greater flexibility and consistency.

The ICD-11 structure emphasizes the common viral etiology (HSV-1 and HSV-2) as a unifying element, recognizing that both viral types can cause infections at any location, although with different frequencies. This change better reflects current epidemiological knowledge, where HSV-1 causes an increasing proportion of genital herpes in some populations.

The definition in ICD-11 explicitly specifies that confirmation is made by identification of virus type 1 or 2, emphasizing the importance of precise etiological diagnosis when possible, aligned with modern diagnostic capabilities.

Practical impact:

For coders and healthcare professionals, the main change is conceptual: thinking of herpes simplex virus infection as a single entity with varied manifestations, rather than multiple conditions separated by location. This simplifies coding in many cases, although subcategories still allow specificity when clinically relevant or required for specific administrative purposes.

Health information systems needed to adapt to this new structure, and there may be a transition period where both systems coexist. The correspondence between ICD-10 and ICD-11 codes should be documented to allow trend analyses and historical comparisons.

9. Frequently Asked Questions

How is the diagnosis of herpes simplex infection made?

The diagnosis is based primarily on characteristic clinical presentation: vesicles grouped on an erythematous base, frequently preceded by prodromal symptoms such as tingling or burning, progressing to pustules and subsequently crusts. In patients with a history of recurrent episodes with a typical pattern, clinical diagnosis is generally sufficient. Laboratory confirmation is recommended in primary infections, atypical presentations, severe cases, or when there are important epidemiological implications. Laboratory methods include PCR (most sensitive and specific), viral culture (less sensitive but specific), antigen detection by immunofluorescence, and serology (useful for distinguishing primary infection from recurrence and identifying previous exposure). The choice of method depends on availability, diagnostic urgency, and specific clinical objectives.

Is treatment available in public health systems?

Antivirals specific for herpes simplex, including acyclovir, valacyclovir, and famciclovir, are widely available in public health systems in many countries, although specific availability varies according to local resources and pharmaceutical policies. Acyclovir, the oldest antiviral and available in generic formulation, is generally accessible in public health services. Treatment can be episodic (during acute outbreaks) or suppressive (continuous use to prevent recurrences in patients with frequent episodes). Mild manifestations may not require antiviral treatment, being managed with supportive measures. Severe, complicated cases, or in immunosuppressed patients generally justify antiviral treatment even in systems with limited resources, due to the risk of significant complications.

How long does treatment last?

The duration of antiviral treatment varies according to clinical presentation. For symptomatic primary infection, typical treatment is seven to ten days. For recurrent episodes, five days of treatment are generally sufficient, and early initiation (ideally during the prodrome or within the first 24-48 hours of lesions) maximizes efficacy. Suppressive treatment for patients with frequent recurrences can be maintained for months to years, with periodic reassessments to determine if it remains indicated. Neonatal herpes or herpetic encephalitis require prolonged intravenous treatment (14-21 days or longer). Individual clinical response and presence of risk factors (immunosuppression) influence decisions about treatment duration.

Can this code be used in medical certificates?

Yes, code 1F00 can be used in medical certificates when appropriate, but considerations regarding privacy and stigma should be weighed. For work or school absences, especially in cases of severe symptomatic primary infection or complications, adequate documentation of the condition is necessary. However, healthcare professionals should be aware that genital herpes, in particular, may carry significant social stigma, and the specificity of information disclosed should balance administrative needs with patient privacy. In some situations, more generic descriptions such as "viral infection" may be sufficient for certificate purposes, reserving specific coding for confidential medical documentation. Legislation regarding privacy of health information varies between jurisdictions and must be respected.

How frequently do recurrences occur?

The frequency of recurrences varies enormously among individuals, from complete absence of recurrences to monthly or more frequent episodes. Factors that influence recurrences include viral type (genital HSV-2 recurs more frequently than genital HSV-1), immune status, physical or emotional stress, sun exposure (for oral herpes), menstruation, local trauma, and other individual triggering factors. Many patients identify specific triggers for their episodes. The frequency of recurrences tends to decrease over time in many individuals. Patients with more than six episodes per year may be candidates for continuous suppressive therapy, which significantly reduces the frequency of recurrences.

Is herpes simplex infection curable?

There is no cure for herpes simplex infection in the sense of complete elimination of the virus from the body. After initial infection, the virus establishes latency in sensory nerve ganglia, where it remains indefinitely. Available antiviral treatments control active viral replication, reduce severity and duration of episodes, decrease frequency of recurrences, and reduce transmission, but do not eradicate latent virus. Research on therapeutic vaccines and strategies to eliminate latent virus is ongoing, but has not yet resulted in approved curative therapies. Most patients learn to live with the condition through appropriate management of episodes and, when indicated, suppressive therapy.

What complications can occur?

Although most herpes simplex infections are self-limited and cause limited morbidity, serious complications can occur. Herpetic encephalitis is the most serious complication, a neurological emergency with high mortality if not treated promptly. Neonatal herpes, acquired during delivery, can cause severe disseminated disease with involvement of multiple organs. Eczema herpeticum occurs in patients with atopic dermatitis, characterized by extensive dissemination of herpetic lesions on compromised skin. Aseptic meningitis, hepatitis, esophagitis, and pneumonitis are rare but recognized complications. Immunosuppressed patients have increased risk of severe, prolonged, or disseminated disease. Ocular infection (herpetic keratitis) can cause visual impairment if not treated appropriately. Psychosocial complications, including anxiety, depression, and impact on relationships, are important but frequently undervalued.

How to prevent transmission?

Prevention of transmission involves multiple strategies. Avoiding direct contact with active lesions is fundamental. For genital herpes, consistent condom use reduces transmission risk, although it does not completely eliminate it due to possible presence of lesions in uncovered areas and asymptomatic viral shedding. Suppressive antiviral therapy in patients with genital herpes significantly reduces transmission to uninfected partners. Patients should be counseled about asymptomatic viral shedding (virus present in secretions even without visible lesions) and its role in transmission. Pregnant women with a history of genital herpes require specific management to prevent neonatal transmission, including suppressive therapy in late pregnancy and, in cases of active lesions at the time of delivery, consideration of cesarean section. Healthcare professionals should use appropriate precautions when handling potentially infectious lesions. Education about the condition, transmission, and preventive strategies is an essential component of management.

Conclusion:

Appropriate coding of herpes simplex infection using ICD-11 code 1F00 requires comprehensive understanding of clinical presentation, diagnostic methods, differential diagnoses, and the structure of the classification system. This guide provides a practical framework for healthcare professionals to apply accurate coding, contributing to effective epidemiological surveillance, robust clinical research, and appropriate management of this globally prevalent condition. The transition from ICD-10 to ICD-11 represents an opportunity for improved international standardization and more precise capture of the diversity of manifestations of this common but clinically significant viral infection.

External References

This article was prepared based on reliable scientific sources:

🌍 WHO ICD-11 - Herpes simplex infection
🔬 PubMed Research on Herpes simplex infection
🌍 WHO Health Topics
📋 CDC - Centers for Disease Control
📊 Clinical Evidence: Herpes simplex infection
📋 Ministry of Health - Brazil
📊 Cochrane Systematic Reviews

References verified on 2026-02-03

Herpes Simplex Infection

Partager